Antonio Giordano, MD, PhD, provides an overview of how biomarkers are used to diagnose inflammatory breast cancer and how they help physicians and patients to make treatment decisions. This presentation was part of the Dana-Farber Inflammatory Breast Cancer Program 5th Annual Patient Forum in April 2022.
For more information about Dana-Farber's Inflammatory Breast Cancer Program, please visit us at https://www.dana-farber.org/inflammatory-breast-cancer-program.